(Q37019601)

17 August 2017

1 reference

title

Risk assessment in the patient with established peripheral arterial disease (English)

1 reference

17 August 2017

author

Judith G. Regensteiner

series ordinal

3

object named as

Judith G Regensteiner

1 reference

17 August 2017

4

William R Hiatt

1 reference

17 August 2017

Scott Haugen

1

1 reference

17 August 2017

Ivan P Casserly

series ordinal

2

1 reference

17 August 2017

publication date

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

12

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

343-350

1 reference

Risk stratification in secondary prevention: advances in multimarker profiles, or back to basics?

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Can we improve cardiovascular risk prediction beyond risk equations in the physician's office?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Ankle/brachial blood pressure in men >70 years of age and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Relation of borderline peripheral arterial disease to cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Peripheral arterial disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

PAD. Epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

One-year cardiovascular event rates in outpatients with atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Cellular adhesion molecules and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Genetic susceptibility to myocardial infarction and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Statin use and functional decline in patients with and without peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07083278

21 January 2018

Identifiers

DOI

10.1177/1358863X07083278

1 reference

17 August 2017

1 reference